Craft

Stevanato Group

Stock Price

$18.8

2024-10-29

Market Capitalization

$5.1 B

2024-10-29

Revenue

€1.1 B

FY, 2023

Stevanato Group Summary

Company Summary

Overview
Stevanato Group is a company that provides integrated drug containment and delivery solutions for the biopharmaceutical industry. It operates through two segments: Biopharmaceutical and Diagnostic Solutions and Engineering. The Biopharmaceutical and Diagnostic Solutions segment comprises products, processes, and services developed for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. The Engineering segment offers equipment and technologies designed to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes, including assembly, visual inspection, packaging and serialization, and glass conversion.
Type
Public
Status
Active
Founded
1949
HQ
Piombino Dese, IT | view all locations
Website
https://www.stevanatogroup.com/en
Cybersecurity rating
ESG rating
50-59 out of 100|View all ESG data
Sectors

Key People

  • Sergio Stevanato

    Sergio Stevanato, Chairman of the Board Emeritus

    • Mauro Stocchi

      Mauro Stocchi, Chief Business Officer

    • Marco dal Lago

      Marco dal Lago, Chief Financial Officer

    • Franco Stevanato

      Franco Stevanato, Executive Chairman of the Board

      LocationsView all

      2 locations detected

      • Piombino Dese, Veneto HQ

        Italy

        Via Molinella, 17

      • Oceanside, CA

        United States

        3233 Roymar Rd

      Stevanato Group Financials

      Summary Financials

      Revenue (Q3, 2024)
      €277.8M
      Gross profit (Q3, 2024)
      €75.8M
      Net income (Q3, 2024)
      €30.0M
      EBIT (Q3, 2024)
      €41.1M
      Enterprise value
      $5.4B

      Footer menu